Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Mollii 2.0

Reference number
Coordinator Inerventions AB, Danderyd - Inerventions AB
Funding from Vinnova SEK 200 000
Project duration May 2019 - September 2019
Status Completed
Venture Medtech4Health: Competence Enhancement in SME
Call Medtech4Health: competence enhancement for smaller companies

Important results from the project

The Mollii suit is a medical device, developed for stimulation of muscles and reduction of spasticity. Mollii can improve mobility and thereby contribute to improved quality of life in people with diagnoses such as cerebral palsy, stroke or multiple sclerosis. The aim of the present project has been to increase the company´s knowledge about the processes that the electrical stimulation creates in the body and the technical possibilities to improve the product´s efficiency and application. This goal has been achieved.

Expected long term effects

To increase knowledge and enable further development of the present version of the Mollii suit, Inerventions has collaborated with experts on subcutaneous electrostimulation from the Medical University of Vienna in Vienna, Austria. This has resulted in the finding of relevant scientific literature as well as explanatory models for the physiological characteristics of the suit. This will, in turn, contribute to increased knowledge within the company

Approach and implementation

In the present project, representatives from Inerventions and the Medical University of Vienna in Vienna, Austria have had contact by telephone, mail and through meetings. In the meetings, documents, knowledge and experiences have been exchanged and important decisions for future development of the product have been made.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 4 June 2019

Reference number 2019-02664